We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Source Bioscience LifeSciences Aquires imaGenes GmbH
News

Source Bioscience LifeSciences Aquires imaGenes GmbH

Source Bioscience LifeSciences Aquires imaGenes GmbH
News

Source Bioscience LifeSciences Aquires imaGenes GmbH

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Source Bioscience LifeSciences Aquires imaGenes GmbH"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

imaGenes is a premier provider of genome research services and products in Europe, managing a comprehensive clone collection and offering an exciting range of services including microarray, protein arrays and DNA sequencing. imaGenes’ high end bioinformatic expertise complement the Group’s investment in leading edge next generation sequencing.

 Dr Nick Ash, CEO of Source BioScience, said: “The acquisition of imaGenes provides a platform for increased penetration of the European life science research and healthcare markets, acting as a catalyst for accelerated growth. The imaGenes team will bring significant depth of experience and knowledge to the Group and we will be able to leverage their existing links with academic centres and research institutions across Europe.”

Advertisement